StonvexLoading…
StonvexCore line items from AU's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $9.89B | $5.79B | $4.58B | $4.50B |
Operating Income | $4.28B | $1.67B | $63.00M | $472.00M |
Net Income | $3.17B | $1.05B | $-222.00M | $251.00M |
EPS (Diluted) | $5.18 | $2.33 | $-0.56 | $0.55 |
Total Assets | $15.08B | $13.23B | $8.26B | $8.01B |
Total Liabilities | $5.16B | $4.72B | $4.52B | $3.94B |
Cash & Equivalents | $2.90B | $1.43B | $964.00M | $1.11B |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 505.01M | 503.53M | 419.73M | 0 |